![Antharis Therapeutics](https://gocience.com/logos/new/6edddb5310b2f9238a03c2855f2c217546b41bdec31523121497347d0e8147d0.jpg)
Antharis Therapeutics
Biotechnology, San Diego, California, United States, 11-50 Employees
Who is ANTHARIS THERAPEUTICS
Antharis Therapeutics is a multinational biopharmaceutical company developing new treatments for cancer, inflammatory and infectious diseases. In particular, our company utilizes cutting-...
Read More
![map](/x-assets/maps1.0-950f22e3512fa69a51fdf6612dcb593a74c2f8790b6e4ec5601cebb82b592ab9.png)
-
Headquarters: San Diego, California, United States
-
Date Founded: 2020
-
Employees: 11-50
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8731
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from ANTHARIS THERAPEUTICS
Antharis Therapeutics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Antharis Therapeutics
Answer: Antharis Therapeutics's headquarters are located at San Diego, California, United States
Answer: Antharis Therapeutics's official website is https://antharistherapeutics.com
Answer: Antharis Therapeutics's revenue is Under $1 Million
Answer: Antharis Therapeutics's SIC: 8731
Answer: Antharis Therapeutics's NAICS: 541714
Answer: Antharis Therapeutics has 11-50 employees
Answer: Antharis Therapeutics is in Biotechnology
Answer: Antharis Therapeutics contact info: Phone number: Website: https://antharistherapeutics.com
Answer: Antharis Therapeutics is a multinational biopharmaceutical company developing new treatments for cancer, inflammatory and infectious diseases. In particular, our company utilizes cutting-edge science to develop therapeutic monoclonal antibodies and antibody-drug conjugates with the end goal of treating unmet medical needs. The company, founded by Dr. Raphael R Pinaud in 2020, has significantly grown and successfully advanced its mission to date. Furthermore, Antharis strategically acquired Cassyni Biopharma and Galileo Biotech, in mid-2022 and mid-2023, respectively, to further and more effectively advance its mandate to bring transformational therapies to patients in need.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month